Position in ABBV
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,467,622
+$43,901 QoQ
Shares Held
6,748
+8.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2025CallValue
$22,849
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DGS Capital Management, LLC holds $21,433,187 across 14 Drug Manufacturers - General names. ABBV ranks #7 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,631 | $3,331,961 | |
| 2 | NVS |
Novartis AG
|
21,135 | $3,228,371 | |
| 3 | LLY |
ELI LILLY & Co
|
3,475 | $3,196,200 | |
| 4 | GSK |
GSK plc
|
42,695 | $2,356,337 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,029 | $1,955,221 | |
| 6 | MRK |
Merck & Co., Inc.
|
14,018 | $1,686,225 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
6,748 | $1,467,622 | |
| 8 | NVO |
Novo Nordisk A S
|
31,948 | $1,174,089 |
All Filings in ABBV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,467,622 | 6,748 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $22,849 | 100 | Call | Sole | 2026-02-24 | |
| 2025-12-31 | $1,423,721 | 6,231 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $1,365,391 | 5,897 | Shares | Sole | 2026-02-24 | |
| 2025-06-30 | $971,535 | 5,234 | Shares | Sole | 2026-02-24 | |
| 2025-03-31 | $944,935 | 4,510 | Shares | Sole | 2026-02-24 | |
| 2024-12-31 | $622,127 | 3,501 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $663,730 | 3,361 | Shares | Sole | 2024-12-10 | |
| 2024-06-30 | $512,844 | 2,990 | Shares | Sole | 2024-12-10 | |
| 2024-03-31 | $597,105 | 3,279 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $382,001 | 2,465 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $392,773 | 2,635 | Shares | Sole | 2024-01-30 | |
| 2023-06-30 | $324,295 | 2,407 | Shares | Sole | 2024-01-30 | |
| 2023-03-31 | $384,081 | 2,410 | Shares | Sole | 2023-06-16 | |
| 2022-12-31 | $414,044 | 2,562 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $326,398 | 2,432 | Shares | Sole | 2023-02-21 | |
| 2022-06-30 | $342,925 | 2,239 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $267,967 | 1,653 | Shares | Sole | 2022-05-05 | |
| No filing history on record for this holder in this stock. | ||||||